SERPINB10
gene geneOn this page
Summary
SERPINB10 (serpin family B member 10, HGNC:8942) is a protein-coding gene on chromosome 18q21.3, encoding Serpin B10 (P48595). Protease inhibitor that may play a role in the regulation of protease activities during hematopoiesis and apoptosis induced by TNF.
This gene is a member of the serpin peptidase inhibitor, clade B family and is found in a cluster of other similar genes on chromosome 18. The protein encoded by this gene appears to help control the regulation of protease functions during hematopoiesis. Variations in this gene may increase the risk of prostate cancer.
Source: NCBI Gene 5273 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 59 total
- Druggable target: yes — 1 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_005024
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8942 |
| Approved symbol | SERPINB10 |
| Name | serpin family B member 10 |
| Location | 18q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000242550 |
| Ensembl biotype | protein_coding |
| OMIM | 602058 |
| Entrez | 5273 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000238508
RefSeq mRNA: 1 — MANE Select: NM_005024
NM_005024
CCDS: CCDS11990
Canonical transcript exons
ENST00000238508 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000670280 | 63933048 | 63933203 |
| ENSE00000807425 | 63934838 | 63936111 |
| ENSE00001102654 | 63917965 | 63918102 |
| ENSE00001102656 | 63919788 | 63919905 |
| ENSE00001102661 | 63917456 | 63917521 |
| ENSE00001102662 | 63930045 | 63930187 |
| ENSE00001531122 | 63907958 | 63908040 |
| ENSE00003493563 | 63915502 | 63915678 |
Expression profiles
Bgee: expression breadth broad, 88 present calls, max score 90.45.
FANTOM5 (CAGE): breadth broad, TPM avg 1.9117 / max 203.7974, expressed in 239 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 170661 | 1.2650 | 128 |
| 170660 | 0.3064 | 61 |
| 170632 | 0.2103 | 85 |
| 170633 | 0.1036 | 57 |
| 208584 | 0.0263 | 6 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bone marrow | UBERON:0002371 | 90.45 | gold quality |
| bone marrow cell | CL:0002092 | 87.91 | gold quality |
| type B pancreatic cell | CL:0000169 | 84.34 | gold quality |
| olfactory bulb | UBERON:0002264 | 84.00 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.64 | silver quality |
| monocyte | CL:0000576 | 75.42 | gold quality |
| mononuclear cell | CL:0000842 | 75.34 | gold quality |
| leukocyte | CL:0000738 | 74.46 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 71.78 | gold quality |
| diaphragm | UBERON:0001103 | 68.78 | gold quality |
| hair follicle | UBERON:0002073 | 66.15 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 65.50 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 65.44 | gold quality |
| upper arm skin | UBERON:0004263 | 63.89 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 63.00 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 62.42 | gold quality |
| bronchus | UBERON:0002185 | 62.35 | silver quality |
| stromal cell of endometrium | CL:0002255 | 61.52 | gold quality |
| blood | UBERON:0000178 | 61.30 | gold quality |
| bronchial epithelial cell | CL:0002328 | 60.05 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 59.65 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 59.27 | silver quality |
| tibialis anterior | UBERON:0001385 | 59.11 | silver quality |
| ileal mucosa | UBERON:0000331 | 58.95 | silver quality |
| quadriceps femoris | UBERON:0001377 | 58.59 | gold quality |
| myocardium | UBERON:0002349 | 58.53 | gold quality |
| vastus lateralis | UBERON:0001379 | 58.43 | gold quality |
| thymus | UBERON:0002370 | 58.11 | gold quality |
| cervix epithelium | UBERON:0004801 | 57.82 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 56.86 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9067 | yes | 15.31 |
| E-MTAB-9801 | yes | 6.47 |
| E-ANND-3 | yes | 3.38 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
49 targeting SERPINB10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-7150 | 99.62 | 66.80 | 1322 |
| HSA-MIR-3171 | 99.49 | 69.06 | 776 |
| HSA-MIR-5571-5P | 99.49 | 66.99 | 1764 |
| HSA-MIR-653-5P | 99.46 | 67.35 | 1300 |
| HSA-MIR-508-5P | 99.41 | 64.25 | 1248 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-580-5P | 99.28 | 70.94 | 1776 |
| HSA-MIR-520E-5P | 99.27 | 68.90 | 1513 |
| HSA-MIR-4426 | 99.17 | 66.74 | 1949 |
Literature-anchored findings (GeneRIF, showing 6)
- Bomapin is a redox-sensitive nuclear serpin that augments proliferation or apoptosis of leukaemia cells, depending on growth factors availability. (PMID:20433722)
- DGCR2, GPR44 and SerpinB10, found in beta cells, were negative in all other cell types within pancreas and exposed epitopes at the cell surface (PMID:22465717)
- Epithelial SERPINB10 contributes to allergic airway eosinophilic inflammation, at least in part, by regulating the expression of periostin and CCL26. (PMID:30382768)
- SerpinB10, a Serine Protease Inhibitor, Is Implicated in UV-Induced Cellular Response. (PMID:34445206)
- Increased SERPINB10 Expression in Induced Sputum Was Associated with Airway Type 2 Inflammation in Asthma. (PMID:35526531)
- Increased Expression of SERPINB10 Associated with Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps. (PMID:36398030)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Serpinb10 | ENSMUSG00000092572 |
| rattus_norvegicus | Serpinb10 | ENSRNOG00000002417 |
Paralogs (36): SERPINB1 (ENSG00000021355), SERPINB3 (ENSG00000057149), SERPIND1 (ENSG00000099937), SERPINA4 (ENSG00000100665), SERPINE1 (ENSG00000106366), SERPINI2 (ENSG00000114204), SERPINC1 (ENSG00000117601), SERPINA7 (ENSG00000123561), SERPINB6 (ENSG00000124570), SERPINF1 (ENSG00000132386), AGT (ENSG00000135744), SERPINE2 (ENSG00000135919), SERPINA10 (ENSG00000140093), SERPING1 (ENSG00000149131), SERPINH1 (ENSG00000149257), SERPINI1 (ENSG00000163536), SERPINA12 (ENSG00000165953), SERPINB7 (ENSG00000166396), SERPINB8 (ENSG00000166401), SERPINB12 (ENSG00000166634), SERPINF2 (ENSG00000167711), SERPINA9 (ENSG00000170054), SERPINA6 (ENSG00000170099), SERPINB9 (ENSG00000170542), SERPINA11 (ENSG00000186910), SERPINA5 (ENSG00000188488), SERPINA3 (ENSG00000196136), SERPINA1 (ENSG00000197249), SERPINB2 (ENSG00000197632), SERPINB13 (ENSG00000197641), SERPINB11 (ENSG00000206072), SERPINB4 (ENSG00000206073), SERPINB5 (ENSG00000206075), HMSD (ENSG00000221887), SERPINE3 (ENSG00000253309), SERPINA2 (ENSG00000258597)
Protein
Protein identifiers
Serpin B10 — P48595 (reviewed: P48595)
Alternative names: Bomapin, Peptidase inhibitor 10
All UniProt accessions (1): P48595
UniProt curated annotations — full annotation on UniProt →
Function. Protease inhibitor that may play a role in the regulation of protease activities during hematopoiesis and apoptosis induced by TNF. May regulate protease activities in the cytoplasm and in the nucleus.
Subcellular location. Nucleus. Cytoplasm.
Tissue specificity. Expressed specifically in myeloid cells and the bone marrow.
Similarity. Belongs to the serpin family. Ov-serpin subfamily.
RefSeq proteins (1): NP_005015* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000215 | Serpin_fam | Family |
| IPR023795 | Serpin_CS | Conserved_site |
| IPR023796 | Serpin_dom | Domain |
| IPR036186 | Serpin_sf | Homologous_superfamily |
| IPR042178 | Serpin_sf_1 | Homologous_superfamily |
| IPR042185 | Serpin_sf_2 | Homologous_superfamily |
Pfam: PF00079
UniProt features (13 total): sequence variant 7, mutagenesis site 2, chain 1, short sequence motif 1, site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P48595-F1 | 88.99 | 0.75 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 362–363 (reactive bond)
Disulfide bonds (1): 68–395
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 74–77 | abolishes nuclear localization. |
| 395 | no effect on cell proliferation. |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6798695 | Neutrophil degranulation |
| R-HSA-168249 | Innate Immune System |
| R-HSA-168256 | Immune System |
MSigDB gene sets: 80 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOCC_SECRETORY_GRANULE, BROWNE_HCMV_INFECTION_48HR_DN, chr18q22, TGGAAA_NFAT_Q4_01, GOCC_SECRETORY_VESICLE, GOCC_SECRETORY_GRANULE_MEMBRANE, GOMF_PEPTIDASE_REGULATOR_ACTIVITY, GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY, GOMF_ENZYME_INHIBITOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, CHYLA_CBFA2T3_TARGETS_UP, WANG_MLL_TARGETS, RAO_BOUND_BY_SALL4_ISOFORM_A, GOCC_TERTIARY_GRANULE
GO Biological Process (0):
GO Molecular Function (2): serine-type endopeptidase inhibitor activity (GO:0004867), peptidase inhibitor activity (GO:0030414)
GO Cellular Component (8): obsolete extracellular space (GO:0005615), nucleoplasm (GO:0005654), cytosol (GO:0005829), plasma membrane (GO:0005886), secretory granule membrane (GO:0030667), ficolin-1-rich granule membrane (GO:0101003), nucleus (GO:0005634), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Innate Immune System | 1 |
| Immune System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| serine-type endopeptidase activity | 1 |
| endopeptidase inhibitor activity | 1 |
| enzyme inhibitor activity | 1 |
| peptidase activity | 1 |
| peptidase regulator activity | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
| secretory granule | 1 |
| cytoplasmic vesicle membrane | 1 |
| bounding membrane of organelle | 1 |
| secretory granule membrane | 1 |
| tertiary granule | 1 |
| ficolin-1-rich granule | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
706 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SERPINB10 | LYG2 | Q86SG7 | 511 |
| SERPINB10 | BPIFB1 | Q8TDL5 | 472 |
| SERPINB10 | SERPINB4 | P48594 | 423 |
| SERPINB10 | SLC14A1 | Q13336 | 404 |
| SERPINB10 | UPK1B | O75841 | 400 |
| SERPINB10 | IVNS1ABP | Q9Y6Y0 | 400 |
| SERPINB10 | FBF1 | Q8TES7 | 391 |
| SERPINB10 | CRISP3 | P54108 | 388 |
| SERPINB10 | AGO2 | Q9UKV8 | 383 |
| SERPINB10 | CLIP2 | Q9UDT6 | 382 |
| SERPINB10 | SLC4A1 | P02730 | 375 |
| SERPINB10 | OAS1 | P00973 | 371 |
| SERPINB10 | PI15 | O43692 | 370 |
| SERPINB10 | SULT4A1 | Q9BR01 | 368 |
| SERPINB10 | CSTA | P01040 | 359 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SERPINB10 | SRPK1 | psi-mi:“MI:0217”(phosphorylation reaction) | 0.440 |
| CFTR | SERPINB10 | psi-mi:“MI:0915”(physical association) | 0.370 |
| KLK10 | IGLL5 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): SERPINB10 (Affinity Capture-MS), SERPINB10 (PCA), SERPINB10 (Biochemical Activity)
ESM2 similar proteins: A0A090BX51, A2I7M9, A2I7N0, A2I7N2, A5PJK0, A9RA96, B0CMB0, B1MTB7, B1MTC3, B2KI30, B3RFC3, B4USX2, E2RVI8, O08800, O73790, O73860, O75635, P01012, P01013, P01014, P05120, P05544, P09006, P12388, P19104, P29508, P29524, P36952, P48594, P48595, P70124, P70458, P70564, Q03044, Q52L45, Q5I0S8, Q5M8J5, Q5SV42, Q6GLQ1, Q6V115
Diamond homologs: A0A090BX51, A0A0K8RCY5, A0A0K8RJ89, A0A0K8RJV9, A5PJK0, A9RA96, B0CMB0, B1MTB7, B1MTC3, B2KI30, B3RFC3, B4USX2, E2RVI8, O02739, O08800, O35684, O54757, O54758, O54759, O54760, O73790, O73860, O75635, O75830, P01008, P01011, P01012, P01014, P05120, P05619, P12388, P17475, P19104, P22323, P22325, P22922, P23035, P29508, P29524, P30740
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
748 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:63915498:TTA:T | acceptor_loss | 1.0000 |
| 18:63915500:A:AC | acceptor_loss | 1.0000 |
| 18:63915500:A:AG | acceptor_gain | 1.0000 |
| 18:63915500:AG:A | acceptor_gain | 1.0000 |
| 18:63915501:G:GT | acceptor_gain | 1.0000 |
| 18:63915501:GG:G | acceptor_gain | 1.0000 |
| 18:63915501:GGT:G | acceptor_gain | 1.0000 |
| 18:63915501:GGTTT:G | acceptor_gain | 1.0000 |
| 18:63917515:G:GT | donor_gain | 1.0000 |
| 18:63917516:A:T | donor_gain | 1.0000 |
| 18:63917960:TAAAG:T | acceptor_loss | 1.0000 |
| 18:63917961:AAAG:A | acceptor_gain | 1.0000 |
| 18:63917962:AAGGA:A | acceptor_loss | 1.0000 |
| 18:63917963:A:AG | acceptor_gain | 1.0000 |
| 18:63917963:AGG:A | acceptor_loss | 1.0000 |
| 18:63917964:G:A | acceptor_gain | 1.0000 |
| 18:63917964:G:GG | acceptor_gain | 1.0000 |
| 18:63918098:ACAAT:A | donor_gain | 1.0000 |
| 18:63918099:CAAT:C | donor_gain | 1.0000 |
| 18:63918100:AAT:A | donor_gain | 1.0000 |
| 18:63918101:AT:A | donor_gain | 1.0000 |
| 18:63918102:TGTA:T | donor_loss | 1.0000 |
| 18:63918103:G:GG | donor_gain | 1.0000 |
| 18:63918103:GT:G | donor_loss | 1.0000 |
| 18:63918104:T:TC | donor_loss | 1.0000 |
| 18:63918105:AAGT:A | donor_loss | 1.0000 |
| 18:63919902:GAGG:G | donor_gain | 1.0000 |
| 18:63919904:GG:G | donor_gain | 1.0000 |
| 18:63919904:GGGTA:G | donor_loss | 1.0000 |
| 18:63919905:GG:G | donor_gain | 1.0000 |
AlphaMissense
2675 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 18:63930173:T:C | F207L | 0.987 |
| 18:63930175:T:A | F207L | 0.987 |
| 18:63930175:T:G | F207L | 0.987 |
| 18:63934991:T:C | F315L | 0.981 |
| 18:63934993:C:A | F315L | 0.981 |
| 18:63934993:C:G | F315L | 0.981 |
| 18:63930143:T:C | F197L | 0.978 |
| 18:63930145:C:A | F197L | 0.978 |
| 18:63930145:C:G | F197L | 0.978 |
| 18:63930174:T:C | F207S | 0.976 |
| 18:63934874:T:A | W276R | 0.974 |
| 18:63934874:T:C | W276R | 0.974 |
| 18:63930131:T:A | W193R | 0.973 |
| 18:63930131:T:C | W193R | 0.973 |
| 18:63935174:T:C | F376L | 0.972 |
| 18:63935176:C:A | F376L | 0.972 |
| 18:63935176:C:G | F376L | 0.972 |
| 18:63915610:A:C | S34R | 0.969 |
| 18:63915612:C:A | S34R | 0.969 |
| 18:63915612:C:G | S34R | 0.969 |
| 18:63933130:T:C | L239P | 0.966 |
| 18:63934920:T:C | L291P | 0.963 |
| 18:63930133:G:C | W193C | 0.962 |
| 18:63930133:G:T | W193C | 0.962 |
| 18:63930174:T:G | F207C | 0.961 |
| 18:63934923:C:A | P292H | 0.957 |
| 18:63930144:T:C | F197S | 0.953 |
| 18:63933163:T:C | L250P | 0.951 |
| 18:63933169:T:A | I252K | 0.948 |
| 18:63915646:G:C | A46P | 0.946 |
dbSNP variants (sampled 300 via entrez): RS1000102140 (18:63912632 T>A,C), RS1000225277 (18:63927643 G>T), RS1000310770 (18:63907532 G>A,C), RS1000353850 (18:63932494 A>G,T), RS1000406137 (18:63932857 T>C), RS1000575432 (18:63927302 G>A), RS1000618414 (18:63927444 G>C), RS1000652863 (18:63916843 A>C), RS1000789083 (18:63917291 T>C), RS1000908646 (18:63932766 C>T), RS1000960448 (18:63906669 T>C), RS1001215690 (18:63915929 G>T), RS1001224998 (18:63926206 G>T), RS1001232403 (18:63930362 G>C), RS1001386887 (18:63918503 T>C)
Disease associations
OMIM: gene MIM:602058 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008891_21 | Cognitive performance (processing speed) | 8.000000e-06 |
| GCST008916_98 | Asthma | 2.000000e-09 |
| GCST009391_75 | Metabolite levels | 5.000000e-06 |
| GCST011739_11 | Cutaneous leishmaniasis | 2.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004363 | information processing speed |
| EFO:0009767 | glycine measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL5725094 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 1,538 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL1232461 | MOLIBRESIB | 2 | 1,538 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 6.68 | IC50 | 210 | nM | MOLIBRESIB |
PubChem BioAssay actives
1 with measured affinity, of 6 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide | 2178887: Inhibition of SERPINB10 (unknown origin) incubated for 1 hr by colloidal coomassie staining based LC-MS/MS analysis | ic50 | 0.2100 | uM |
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Formaldehyde | increases expression | 2 |
| Tobacco Smoke Pollution | decreases expression | 2 |
| bisphenol A | affects cotreatment, increases methylation | 1 |
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| tamibarotene | decreases expression | 1 |
| perfluorohexanesulfonic acid | increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Demecolcine | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Vincristine | increases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | increases expression | 1 |
ChEMBL screening assays
6 unique, capped per target: 6 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5697617 | Binding | Inhibition of SERPINB10 (unknown origin) assessed as fold change at 10 uM incubated for 1 hr by colloidal coomassie staining based LC-MS/MS analysis | Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. — Nature |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cutaneous leishmaniasis